Revatis Vet SRL
Revatis Vet reported total assets of 614,858 € at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Jul 2026).
The score of Revatis Vet shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Revatis Vet's annual accounts
| 2025 | |
|---|---|
| Net result | −112,410 € |
| Equity | 483,081 € |
| Cash | 71,500 € |
| EBITDA | 3,210 € |
| Total assets | 614,858 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Jul 2026
Revatis Vet's financial analysis
- Solvency78.6%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Revatis Vet
Revatis Vet's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1015.868.627
- VAT number
- BE1015868627
- Peppol
- Registered · 0208:1015868627 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Nov 2024
- Registered office
- 6900 Marche-en-Famenne
- Latest accounts
- 2025 · filed on 21 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Revatis Vet (SRL) has been based in Marche-en-Famenne since 2024, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 112,410 € and equity of 483,081 €; its revenue is not published. Its solvency stands at 78.6%, above the median of its sector (43.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Revatis Vet
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Advanced Instruments (Belgium) Wholesale of pharmaceutical and medical goods Brussels · balance sheet 408,689 €
- Patrimol Wholesale of pharmaceutical and medical goods Stekene · balance sheet 619,408 €
Frequently asked questions about Revatis Vet
What is the revenue of Revatis Vet?
Revatis Vet files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Revatis Vet?
In Belgium, the VAT number is the company number prefixed with BE: BE1015868627 for Revatis Vet, if the company is VAT-registered. Its company number (CBE) is 1015.868.627.
Where is the registered office of Revatis Vet?
According to the CBE register, the registered office of Revatis Vet is in 6900 Marche-en-Famenne.
What is the equity of Revatis Vet?
At the close of the 2025 financial year, the equity of Revatis Vet amounts to 483,081 €, a solvency of 78.6% of total assets.
Who manages Revatis Vet?
The register lists 4 active mandates at Revatis Vet. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Revatis Vet
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →